Labeling Standards for Digital Medical Devices to Be Clarified
MFDS Revises Guidelines to Resolve Labeling Confusion
The Ministry of Food and Drug Safety announced on June 10, 2026, that it had revised the 'Guideline on Labeling for Digital Medical Devices' to address difficulties in labeling requirements for products that have been converted from conventional medical devices to digital medical devices under the Digital Medical Products Act, which came into effect last year.
As some stakeholders raised concerns about challenges in the field due to differences in labeling and management systems for 'converted products' by company, the Ministry actively reflected industry opinions gathered through the 'Medical Device Approval and Review Communication Group' meeting held in April and prepared a revised guideline to improve regulations.
The main revision clarifies the eligible products and the period for which previously certified or reported digital medical devices are allowed to use the former labeling content, specifying that this is permitted until January 23 of next year.
Considering the characteristics of digital medical device software, the guideline specifies that the version information and date of manufacture should be indicated as the 'distribution date of the current software version,' and the serial number should be noted as the 'distribution date of the first produced software version.' Alternatively, companies may flexibly indicate these details in accordance with their own GMP systems.
Taking into account the intangible nature of software products, the guideline clearly states that, in accordance with the Digital Medical Products Act, information about digital medical device software should be provided via the company's website, within the software user interface, through subscriber email, or in other similar ways.
To ensure transparency and the consumer's right to know regarding products using artificial intelligence (AI) technology, the guideline provides explanations and examples about the AI learning methods, information on training data, and the range of expected performance.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The Ministry of Food and Drug Safety stated, "We expect this guideline revision to resolve difficulties in the field for the industry and to contribute to the growth of the digital medical device market and enhanced quality competitiveness," adding, "We will continue to provide a variety of support to ensure the stable implementation of related systems."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.